UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Disposition and metabolism of almotriptan in rats, dogs and monkeys

Xenobiotica, 2006-09, Vol.36 (9), p.807-823

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of food intake on the bioavailability of almotriptan, an antimigraine compound, in healthy volunteers: an open, randomized, crossover, single-dose clinical trial

International journal of clinical pharmacology and therapeutics, 2006-04, Vol.44 (4), p.185

2006

Link zum Volltext

Verfügbarkeit prüfen

Repeated dose pharmacokinetics of pancopride in human volunteers

Biopharmaceutics & drug disposition, 1994-11, Vol.15 (8), p.643-651

1994

Link zum Volltext

Verfügbarkeit prüfen

Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan

Drug metabolism and disposition, 2003-04, Vol.31 (4), p.404

2003

Link zum Volltext

Verfügbarkeit prüfen

Absolute Bioavailability, Pharmacokinetics, and Urinary Excretion of the Novel Antimigraine Agent Almotriptan in Healthy Male Volunteers

Journal of clinical pharmacology, 2002-12, Vol.42 (12), p.1303-1310

2002

Link zum Volltext

Verfügbarkeit prüfen

Bioavaiiability and bioequivalence of two formulations of etodolac (tablets and suppositories)

Journal of pharmaceutical sciences, 1993-02, Vol.82 (2), p.211-213

1993

Link zum Volltext

Verfügbarkeit prüfen

Bioavailability and Bioequivalence of Two Formulations of Etodolac (Tablets and Suppositories)

Journal of pharmaceutical sciences, 1993-02, Vol.82 (2), p.211-213

1993

Link zum Volltext

Verfügbarkeit prüfen

Single dose pharmacokinetics and tolerance of pancopride in healthy volunteers

Arzneimittel-Forschung, 1995-02, Vol.45 (2), p.177

1995

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Studies of the Histamine H1-Receptor Antagonist Ebastine in Dogs

Journal of pharmacy and pharmacology, 1994-07, Vol.46 (7), p.596-599

1994

Link zum Volltext

Verfügbarkeit prüfen

In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations

Arzneimittel-Forschung, 1984, Vol.34 (10A), p.1360

1984

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology and Toxicological Profile of LAS 30538: A New Vascular Selective Ca2+ Channel Blocker

Cardiovascular drug reviews, 1995-03, Vol.13 (1), p.1-18

1995

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic studies of pancopride in rat and dog

European journal of drug metabolism and pharmacokinetics, 1994, p.1-7

1994

Link zum Volltext

Verfügbarkeit prüfen

Repeated dose pharmacokinetic study of the combination of ebastine and pseudoephedrine in healthy volunteers

European journal of drug metabolism and pharmacokinetics, 1994, p.128-132

1994

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of kanamycin analogues

Martinez-Tobed, A

1977

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic study of etodolac after rectal administration; "in vitro" release kinetics

European journal of drug metabolism and pharmacokinetics, 1991, Vol.Spec No 3, p.389-396

1991

Link zum Volltext

Verfügbarkeit prüfen

The synthesis of 2,5-dideoxy-4,6-di- O-(2,3-dideoxy-α-D- erythro-hexopyranosyl)streptamine and 4,6-di- O(6-amino-2,3,6-trideoxy-α-D- erythro-hexopyranosyl)-2,5-dideoxystreptamine

Carbohydrate research, 1979, Vol.68 (1), p.43-53

1979

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of 6-azido- and 6-amino-2,3,6-trideoxy- d- erythro-hexose

Carbohydrate research, 1977-07, Vol.56 (2), p.289-299

1977

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology and Toxicological Profile of LAS 30538: A New Vascular Selective Ca 2+ Channel Blocker

Cardiovascular drug reviews, 1995-03, Vol.13 (1), p.1-18

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(8)

Publikationsform

Sprache

Englisch
(18)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(9)
Medical Sciences
(9)
Pharmacology. Drug Treatments
(9)
Life Sciences & Biomedicine
(8)
Male
(8)
Science & Technology
(8)
Humans
(7)
Pharmacology & Pharmacy
(7)
Adult
(6)
Administration, Oral
(5)
Biological Availability
(5)
Chromatography, High Pressure Liquid
(4)
Female
(4)
Half-Life
(4)
Adolescent
(3)
Cardiovascular System
(3)
Cross-Over Studies
(3)
Digestive System
(3)
Models, Biological
(3)
Serotonin Receptor Agonists - Pharmacokinetics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disposition and metabolism of almotriptan in rats, dogs and monkeys

Effect of food intake on the bioavailability of almotriptan, an antimigraine compound, in healthy volunteers: an open, randomized, crossover, single-dose clinical trial

Repeated dose pharmacokinetics of pancopride in human volunteers

Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan

Absolute Bioavailability, Pharmacokinetics, and Urinary Excretion of the Novel Antimigraine Agent Almotriptan in Healthy Male Volunteers

Bioavaiiability and bioequivalence of two formulations of etodolac (tablets and suppositories)

Bioavailability and Bioequivalence of Two Formulations of Etodolac (Tablets and Suppositories)

Single dose pharmacokinetics and tolerance of pancopride in healthy volunteers

Pharmacokinetic and Pharmacodynamic Studies of the Histamine H1-Receptor Antagonist Ebastine in Dogs

In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations

Pharmacology and Toxicological Profile of LAS 30538: A New Vascular Selective Ca2+ Channel Blocker

Pharmacokinetic studies of pancopride in rat and dog

Repeated dose pharmacokinetic study of the combination of ebastine and pseudoephedrine in healthy volunteers

Synthesis of kanamycin analogues

Pharmacokinetic study of etodolac after rectal administration; "in vitro" release kinetics

The synthesis of 2,5-dideoxy-4,6-di- O-(2,3-dideoxy-α-D- erythro-hexopyranosyl)streptamine and 4,6-di- O(6-amino-2,3,6-trideoxy-α-D- erythro-hexopyranosyl)-2,5-dideoxystreptamine

Synthesis of 6-azido- and 6-amino-2,3,6-trideoxy- d- erythro-hexose

Pharmacology and Toxicological Profile of LAS 30538: A New Vascular Selective Ca 2+ Channel Blocker

Suchergebnisse filtern